Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free PHVS Stock Alerts

Pharvaris (PHVS) Financials

Pharvaris logo
$30.02 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$29.95 -0.07 (-0.23%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Pharvaris

Annual Income Statements for Pharvaris

This table shows Pharvaris' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.94 -9.01 -32 -48 -82 -112 -139 -206
Consolidated Net Income / (Loss)		 -4.94 -9.01 -32 -48 -82 -112 -139 -206
Net Income / (Loss) Continuing Operations		 -4.94 -9.01 -32 -48 -82 -112 -139 -206
Total Pre-Tax Income 		-4.94 -9.01 -32 -48 -81 -110 -137 -204
Total Operating Income		 -4.94 -8.99 -32 -48 -81 -110 -137 -204
Total Gross Profit		 -0.00 0.00 -1.30 13 12 -3.22 14 -4.56
Total Revenue		 0.00 0.00 -1.30 13 12 -3.22 14 -4.56
Operating Revenue		 - - -1.30 13 12 -3.22 14 -4.56
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 4.94 8.99 31 61 93 107 151 199
Selling, General & Admin Expense		 0.76 2.61 6.72 21 31 35 49 53
Research & Development Expense		 4.17 6.38 24 41 61 73 102 146
Total Other Income / (Expense), net		 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00
Income Tax Expense		 0.00 0.00 -0.10 0.08 0.73 1.16 1.89 2.33
Basic Earnings per Share		 ($0.89) - ($5.36) ($1.40) ($2.43) ($2.91) ($2.57) ($3.49)
Weighted Average Basic Shares Outstanding		 - - 4.85M 33.15M 33.82M 52.29M 54.38M 65.21M
Diluted Earnings per Share		 ($0.89) - ($5.36) ($1.40) ($2.43) ($2.91) ($2.57) ($3.49)
Weighted Average Diluted Shares Outstanding		 - - 4.85M 33.15M 33.82M 52.29M 54.38M 65.21M
Weighted Average Basic & Diluted Shares Outstanding		 - - 4.85M 33.15M 33.82M 52.29M 54.38M 65.21M

Quarterly Income Statements for Pharvaris

No quarterly income statements for Pharvaris are available.

Annual Cash Flow Statements for Pharvaris

This table details how cash moves in and out of Pharvaris' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.68 17 97 112 -63 257 -122 -0.02
Net Cash From Operating Activities		 -4.48 -7.49 -26 -50 -72 -103 -124 -0.02
Net Cash From Continuing Operating Activities		 -4.66 -8.81 -29 -50 -79 -102 -135 -0.02
Net Income / (Loss) Continuing Operations		 -4.94 -9.01 -32 -48 -81 -110 -137 0.00
Depreciation Expense		 0.00 0.00 0.01 0.09 0.16 0.28 0.28 0.49
Non-Cash Adjustments To Reconcile Net Income		 0.12 0.13 3.71 -4.07 0.11 13 0.71 -0.52
Net Cash From Investing Activities		 0.00 -0.02 -0.05 -0.15 -0.13 -0.10 -0.56 0.00
Net Cash From Continuing Investing Activities		 0.00 -0.02 -0.05 -0.15 -0.13 -0.10 -0.56 0.00
Net Cash From Financing Activities		 5.16 24 124 163 9.25 360 2.77 0.00
Net Cash From Continuing Financing Activities		 5.16 24 124 -15 -0.13 -0.24 -0.17 0.00
Cash Interest Received		 - - - - - - - 0.48

Quarterly Cash Flow Statements for Pharvaris

No quarterly cash flow statements for Pharvaris are available.

Annual Balance Sheets for Pharvaris

This table presents Pharvaris' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 23 124 240 179 441 302 354
Total Current Assets		 23 123 239 178 440 300 351
Cash & Equivalents		 23 120 237 173 433 291 342
Current Deferred & Refundable Income Taxes		 - - - 0.41 1.15 3.05 5.34
Other Current Assets		 0.05 2.14 1.71 4.95 6.17 5.95 3.45
Plant, Property, & Equipment, net		 0.01 0.06 0.12 0.21 0.25 0.69 0.75
Plant, Property & Equipment, gross		 0.01 0.06 0.12 0.21 0.25 0.69 0.75
Total Noncurrent Assets		 0.00 0.00 0.47 0.74 0.69 1.33 1.93
Noncurrent Deferred & Refundable Income Taxes		 - - 0.19 0.28 0.43 0.49 1.04
Other Noncurrent Operating Assets		 - 0.00 0.28 0.46 0.26 0.84 0.89
Total Liabilities & Shareholders' Equity		 23 124 240 179 441 302 354
Total Liabilities		 2.16 6.49 8.08 20 16 24 35
Total Current Liabilities		 2.16 6.47 7.76 19 16 23 34
Accounts Payable		 0.58 1.01 2.82 7.15 3.22 4.72 6.00
Accrued Expenses		 1.58 5.46 4.83 12 12 18 27
Other Current Liabilities		 - 0.00 0.11 0.20 0.22 0.23 0.23
Total Noncurrent Liabilities		 0.00 0.00 0.17 0.27 0.05 0.66 0.68
Capital Lease Obligations		 - - 0.17 0.27 0.05 0.66 0.68
Total Equity & Noncontrolling Interests		 21 117 232 160 425 277 318
Total Preferred & Common Equity		 21 117 232 160 425 277 318
Preferred Stock		 41 169 315 309 681 646 930
Total Common Equity		 -20 -52 -84 -150 -256 -368 -612
Common Stock		 0.15 0.29 4.50 4.34 6.94 6.75 9.18
Retained Earnings		 -21 -54 -99 -176 -294 -416 -680
Other Equity Adjustments		 0.44 2.41 11 22 31 41 59

Quarterly Balance Sheets for Pharvaris

No quarterly balance sheets for Pharvaris are available.

Annual Metrics And Ratios for Pharvaris

This table displays calculated financial ratios and metrics derived from Pharvaris' official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - 65,210,590.00
DEI Adjusted Shares Outstanding		 - - - - - - - 65,210,590.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - -3.16
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 1,100.99% -8.91% -127.23% 527.01% -133.17%
EBITDA Growth		 0.00% -82.45% -253.43% -51.38% -67.59% -36.37% -24.17% -48.71%
EBIT Growth		 0.00% -82.46% -253.51% -51.62% -67.62% -36.44% -24.10% -48.76%
NOPAT Growth		 0.00% -82.07% -254.25% -51.62% -67.62% -36.44% -24.10% -48.76%
Net Income Growth		 0.00% -82.46% -252.38% -52.35% -68.85% -36.65% -24.51% -48.42%
EPS Growth		 0.00% 0.00% 0.00% 73.88% -62.14% -15.86% 11.77% -35.79%
Operating Cash Flow Growth		 0.00% -67.08% -250.50% -92.19% -42.34% -43.26% -20.81% 99.98%
Free Cash Flow Firm Growth		 0.00% 0.00% -363.57% -58.98% -48.67% -69.82% -10.46% -45.46%
Invested Capital Growth		 0.00% 0.00% -92.72% -30.54% -172.06% 41.54% -63.54% -82.60%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 100.00% 100.00% 0.00% 100.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% -371.00% -682.57% 0.00% -994.06% 0.00%
Operating Margin		 0.00% 0.00% 0.00% -371.67% -683.96% 0.00% -996.09% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% -371.67% -683.96% 0.00% -996.09% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% -372.29% -690.10% 0.00% -1,009.82% 0.00%
Tax Burden Percent		 100.00% 100.00% 99.68% 100.16% 100.90% 101.05% 101.38% 101.14%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -42.99% -46.02% -27.72% -41.70% -38.18% -39.58% -69.25%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% -26.56% -38.59% 0.00% -36.91% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% -26.61% -38.93% 0.00% -37.42% 0.00%
Return on Common Equity (ROCE)		 0.00% 41.32% 23.93% 10.73% 24.83% 26.52% 35.23% 113.97%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -42.99% -27.13% -20.85% -51.14% -26.27% -50.13% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.46 -6.29 -22 -34 -57 -77 -96 -143
NOPAT Margin		 0.00% 0.00% 0.00% -260.17% -478.77% 0.00% -697.26% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% -23.81% -13.18% -8.15% -12.23% -11.34% -11.92% -20.16%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - -34.53% -44.73%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 159.87% 265.24% 0.00% 354.54% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 311.81% 518.71% 0.00% 741.54% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 471.67% 783.96% 0.00% 1,096.09% 0.00%
Earnings before Interest and Taxes (EBIT)		 -4.94 -9.01 -32 -48 -81 -110 -137 -204
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.94 -9.01 -32 -48 -81 -110 -137 -203
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 5.37 31.52 0.00 72.86 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 11.43 43.05 0.00 98.71 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -1.09 -1.04 -1.02 -1.04 -1.03 -1.03 -1.06
Leverage Ratio		 0.00 1.10 1.06 1.04 1.07 1.06 1.06 1.10
Compound Leverage Factor		 0.00 1.10 1.06 1.04 1.07 1.06 1.06 1.10
Debt to Total Capital		 0.00% 0.00% 0.00% 0.07% 0.17% 0.01% 0.24% 0.21%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.07% 0.17% 0.01% 0.24% 0.21%
Preferred Equity to Total Capital		 0.00% 196.13% 144.11% 135.90% 193.42% 160.33% 232.36% 291.54%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -96.13% -44.11% -35.98% -93.59% -60.34% -132.59% -191.75%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 4.91 2.14 3.93 2.12 1.68
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 -0.01 0.00 0.00 -0.01 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 7.01 3.05 5.60 3.02 2.39
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -0.01 0.00 0.00 -0.01 0.00
Altman Z-Score		 0.00 44.51 14.95 5.15 9.60 34.52 22.32 22.03
Noncontrolling Interest Sharing Ratio		 0.00% 196.13% 152.01% 138.72% 159.54% 169.47% 189.00% 264.58%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 10.70 19.06 30.84 9.39 28.07 12.94 10.44
Quick Ratio		 0.00 10.67 18.72 30.62 9.11 27.60 12.55 10.18
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -4.44 -21 -33 -49 -83 -91 -133
Operating Cash Flow to CapEx		 0.00% -49,546.04% -50,025.73% -34,299.06% -54,034.37% -103,406.58% -22,325.46% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.07 0.06 0.00 0.04 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 17.46 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 143.07 71.86 0.00 29.34 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 20.91 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 20.91 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 -1.85 -3.57 -4.67 -13 -7.42 -12 -22
Invested Capital Turnover		 0.00 0.00 0.00 -3.15 -1.36 0.00 -1.41 0.00
Increase / (Decrease) in Invested Capital		 0.00 -1.85 -1.72 -1.09 -8.03 5.27 -4.72 -10
Enterprise Value (EV)		 0.00 184 214 148 509 1,197 1,358 2,098
Market Capitalization		 165 165 165 70 373 949 1,002 1,509
Book Value per Share		 $0.00 ($2.44) ($10.64) ($17.22) ($4.52) ($7.58) ($7.04) ($11.25)
Tangible Book Value per Share		 $0.00 ($2.44) ($10.64) ($17.22) ($4.52) ($7.58) ($7.04) ($11.25)
Total Capital		 0.00 21 117 232 160 425 278 319
Total Debt		 0.00 0.00 0.00 0.17 0.27 0.05 0.66 0.68
Total Long-Term Debt		 0.00 0.00 0.00 0.17 0.27 0.05 0.66 0.68
Net Debt		 0.00 -23 -120 -237 -173 -433 -290 -342
Capital Expenditures (CapEx)		 0.00 0.02 0.05 0.15 0.13 0.10 0.56 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -1.87 -3.63 -5.26 -14 -8.35 -14 -25
Debt-free Net Working Capital (DFNWC)		 0.00 21 117 232 159 424 276 317
Net Working Capital (NWC)		 0.00 21 117 232 159 424 276 317
Net Nonoperating Expense (NNE)		 1.48 2.72 9.45 15 25 34 43 63
Net Nonoperating Obligations (NNO)		 0.00 -23 -121 -237 -172 -432 -289 -341
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.01 0.09 0.16 0.28 0.28 0.49
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% -40.48% -115.30% 0.00% -102.94% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 1,783.47% 1,347.81% 0.00% 2,009.12% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 1,783.47% 1,347.81% 0.00% 2,009.12% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($5.36) $0.00 ($2.27) ($2.63) ($2.57) ($3.49)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 4.85M 33.15M 33.82M 52.29M 54.38M 65.21M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($5.36) $0.00 ($2.27) ($2.63) ($2.57) ($3.49)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 4.85M 33.15M 33.82M 52.29M 54.38M 65.21M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($5.36) $0.00 ($2.27) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 4.85M 33.15M 33.82M 52.29M 54.38M 65.21M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.46 -6.29 -22 -34 -57 -77 -96 -143
Normalized NOPAT Margin		 0.00% 0.00% 0.00% -260.17% -478.77% 0.00% -697.26% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% -371.67% -683.96% 0.00% -996.09% 0.00%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -10.42% -5.06% -30.78% -1.10% -17.15% 0.00% 0.00%

Quarterly Metrics And Ratios for Pharvaris

No quarterly metrics and ratios for Pharvaris are available.


Financials Breakdown Chart

Frequently Asked Questions About Pharvaris' Financials

When does Pharvaris' financial year end?

According to the most recent income statement we have on file, Pharvaris' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Pharvaris' net income changed over the last 7 years?

Pharvaris' net income appears to be on an upward trend, with a most recent value of -$206.20 million in 2025, rising from -$4.94 million in 2018. The previous period was -$138.93 million in 2024. Check out Pharvaris' forecast to explore projected trends and price targets.

What is Pharvaris' operating income?
Pharvaris' total operating income in 2025 was -$203.87 million, based on the following breakdown:
  • Total Gross Profit: -$4.56 million
  • Total Operating Expenses: $199.30 million
How has Pharvaris' revenue changed over the last 7 years?

Over the last 7 years, Pharvaris' total revenue changed from $0.00 in 2018 to -$4.56 million in 2025, a change of -456,361,871.0%.

How much debt does Pharvaris have?

Pharvaris' total liabilities were at $35.42 million at the end of 2025, a 44.9% increase from 2024, and a 1,540.3% increase since 2019.

How much cash does Pharvaris have?

In the past 6 years, Pharvaris' cash and equivalents has ranged from $22.81 million in 2019 to $432.78 million in 2023, and is currently $342.31 million as of their latest financial filing in 2025.

How has Pharvaris' book value per share changed over the last 7 years?

Over the last 7 years, Pharvaris' book value per share changed from 0.00 in 2018 to -11.25 in 2025, a change of -1,125.0%.


Related Companies

Financial statements for NASDAQ:PHVS last updated on 4/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel